Page last updated: 2024-09-03

pak 104p and 3,3'-diethyloxacarbocyanine

pak 104p has been researched along with 3,3'-diethyloxacarbocyanine in 1 studies

Compound Research Comparison

Studies
(pak 104p)
Trials
(pak 104p)
Recent Studies (post-2010)
(pak 104p)
Studies
(3,3'-diethyloxacarbocyanine)
Trials
(3,3'-diethyloxacarbocyanine)
Recent Studies (post-2010) (3,3'-diethyloxacarbocyanine)
16002405

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Minderman, H; Minderman, MD; Rustum, YM; Slovak, ML; Toth, K; Vanhoefer, U; Wrzosek, C; Yin, MB1

Other Studies

1 other study(ies) available for pak 104p and 3,3'-diethyloxacarbocyanine

ArticleYear
DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux.
    Cytometry, 1996, Sep-01, Volume: 25, Issue:1

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carbocyanines; Cyclic P-Oxides; Doxorubicin; Drug Resistance, Multiple; Female; Flow Cytometry; Fluorescent Dyes; Humans; Neoplasm Proteins; Nicotinic Acids; Rhodamine 123; Rhodamines; Tumor Cells, Cultured

1996